The Centers for Medicare and Medicaid Services announced higher-than-expected Medicare Advantage payment rate increases for 2026.

Raymond James upgraded HealthEquity (NASDAQ:HQY) from Outperform to Strong Buy, setting a new price target of $115, slightly below the previous $120, citing confidence in the company’s ability to ...

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

Raymond James upgraded HealthEquity (HQY) to Strong Buy from Outperform with a price target of $115, down from $120. The firm upgrade the ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS:HQY) from Outperform ...

HealthEquity divulged its fourth-quarter and ... Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

Over the past few days HealthEquity (NASDAQ: HQY) shares have been rather sickly. The health savings account (HSA) specialist's stock was rocked by a disappointing earnings report, and as a result ...

The healthcare finance company posted its final set of financials for its fiscal 2024. These fell short of expectations on several metrics. HealthEquity divulged its fourth-quarter and full-year ...

HealthEquity, Inc. HQY recently introduced ... potentially driving up the stock price. Meanwhile, HQY currently has a market capitalization of $8.81 billion. The company delivered an average ...

potentially driving up the stock price. Meanwhile, HQY currently has a market capitalization of $8.81 billion. The company delivered an average earnings surprise of 12.8% in the trailing four quarters ...